is retatrutide approved 2025 HAS NOT BEEN YET & CURRENTLY IN PHASE III CLINICAL TRIALS⛔️ Retatrutide not currently FDA-approved, as it is in Phase III clinical trials with anticipated completion in 2025–2026 and How to Get Retatrutide in

For ongoing support, TrimRX offers customized GLP-1 programs starting at $199 for Injectable Semaglutide

M.GhateiM

Regional Insights North America was the largest region in the GLP-1 receptor agonist market in 2025

What Comes With Your MEDVi Plan Doctor-Approved Personalized Plan: A licensed clinician evaluates your health profile and builds a GLP-1 weight loss treatment plan specifically for you

Published clinical studies have evaluated investigational retatrutide under controlled research conditions, but those findings should not be interpreted as evidence that this research product is approved for patient care

Additionally, individuals with a recent history of serious conditions such as pancreatitis, thyroid cancer, or other exclusions specific to the study may not qualify